Press Review… Winter 2026 Press Review – Rheumatology (Oxford) 18 Jan 2026 August 2025 to November 2025 Author: Hannah den Braanker Long-Term Effects of Selexipag in SSc-Associated Digital Ulcers Iannone et al. (10.1093/rheumatology) evaluated the long-term efficacy of selexipag in treating digital ulcers (DUs)…
Arthritis Research and Therapy… Winter 2026 Press Review – Arthritis Research & Therapy 18 Jan 2026 August 2025 to November 2025 Author: Nikolaos Vlachogiannis IL-17A Blockade Modulates Inflammatory and Stromal Pathwaysin Peripheral Spondyloarthritis Ihsan Hammoura et al. (10.1186/s13075-025-03638-0) found that IL-17A inhibition (IL-17Ai) profoundly alters synovial gene…
Arthritis Care and Research… Winter 2026 Press Review – Arthritis Care and Research 18 Jan 2026 August 2025 to November 2025 Author: Victoria Sadovici-Bobeica 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis Sammaritano LR et al. (10.1002/art.43212) in this…
Arthritis and Rheumatology… Winter 2026 Press Review – Arthritis & Rheumatology 18 Jan 2026 August 2025 to November 2025 Author: Victoria Sadovici-Bobeica Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis Wechsler ME et al. (10.1002/art.43146) in this open-label extension of the…
Press Review… Winter 2026 Press Review – RMD Open 18 Jan 202618 Jan 2026 August 2025 to November 2025 Author: Giovanni Fulvio ‘Fast Ossifier’ in diffuse idiopathic skeletal hyperostosis: a sex-modulated, heterogeneous phenotype with accelerated ossification and early trabecular decline Pariente-Rodrigo et al. (10.1136/rmdopen-2025-006024) found…
Press Review… Winter 2026 Press Review – The Lancet Rheumatology 18 Jan 2026 August 2025 to November 2025 Author: Nikolaos Vlachogiannis Effectiveness of treat-to-target tapering of TNF inhibitors in spondyloarthritides: a 24-month follow-up study Amy C D Peeters et al. (10.1016/s2665-9913(25)00070-0) examined whether a…
EULAR Rheumatology open… Winter 2026 Press Review – Miscellaneous 18 Jan 202618 Jan 2026 August 2025 to November 2025 Author: Maxime Melchior Effects of Long-Term Ixazomib on Bone Mass in Multiple Myeloma Levring et al. (10.1016/j.bone.2025.117660) investigated the impact of ixazomib (an oral proteasome inhibitor)…
EMEUNET… Stats Made Simple: Interpreting tables, graphs, and figures 18 Jan 202616 Mar 2026 What quickly sets experienced readers apart is how efficiently they can extract key information from figures and tables in a scientific article. Each type of scientific publication follows a relatively…
Obesity… Obesity as a risk factor for rheumatic diseases – epidemiological insights 10 Dec 202511 Dec 2025 Obesity is increasingly recognised as a major modifiable risk factor for the development and progression of several rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), osteoarthritis (OA), systemic lupus…
Obesity… Beyond Body Weight: Obesity’s Impact on Therapeutic Response in rheumatic diseases 10 Dec 202511 Dec 2025 Obesity poses a dual challenge in inflammatory arthritis: it increases disease risk and reduces treatment effectiveness. Studies show that obesity is independently linked to higher disease activity and weaker response…